JBCHEPHARM - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 19 Sept 25, 2:16 pm

Technical Rating: 3.7

Here’s a detailed technical analysis of J.B. Chemicals & Pharmaceuticals Ltd (JBCHEPHARM)

📊 Trend Overview

Phase: Reversing with bearish undertone

Price Action: Trading below both 50-DMA (₹1,705) and 200-DMA (₹1,699), indicating short-term weakness and a potential trend reversal.

Volume: Above average (1.37L vs 1.01L), suggesting increased activity, possibly driven by speculative interest or institutional repositioning.

📈 Momentum Indicators

RSI (43.6): Weak zone — momentum is softening, approaching oversold territory.

MACD (-5.87): Negative and diverging — confirms bearish momentum and lack of short-term strength.

Bollinger Bands: Price likely near the lower band, indicating oversold conditions and potential for a technical bounce.

🧭 Chart Patterns

Descending Channel: Price has been declining from ₹1,998, forming lower highs and lower lows.

Base Formation Attempt: Stabilization near ₹1,650–₹1,690 zone suggests potential bottoming, but confirmation is lacking.

🔍 Support & Resistance Levels

Level Price (₹) Commentary

Support 1 1,650 Minor pullback zone

Support 2 1,580 Previous swing low

Support 3 1,500 Psychological support

Resistance 1 1,705 50-DMA, short-term ceiling

Resistance 2 1,750 Breakdown zone

Major Resistance 1,998 52-week high

🎯 Entry & Exit Zones

Optimal Entry: ₹1,650–₹1,690 (on dips with reversal confirmation)

Short-Term Target: ₹1,705–₹1,750

Exit Zone / Stop-Loss: ₹1,580 (below swing support)

🔄 Short-Term Outlook

Momentum: Weak and declining

Bias: Bearish below ₹1,705; neutral-to-bullish only above ₹1,750

Phase: Reversing — early signs of base formation but no breakout yet

🧠 Key Takeaways

JBCHEPHARM is showing signs of short-term weakness despite strong quarterly profit growth.

RSI and MACD confirm bearish momentum, while price action suggests a possible retest of support near ₹1,650.

A close above ₹1,705 with volume could revive bullish sentiment and open upside toward ₹1,750–₹1,998.

Let me know if you’d like a chart visualization or screener of similar pharma sector reversal setups.

Edit in a page